cancer cases
CUP outcome
therapy of CUP cases
pharmacological treatment of CUP cases
ncRNA DNA methylation assay
identified primary tumor
epigenotyping Cancer of Unknown Primary
ncRNA DNA Methylation Kit
Human Cancer
primary tumor site of origin
DNA methylation profile of non-coding RNA
Treatment Guidance
CpG methylation changes
personalized drug treatment
diagnoses of CUPs
Non-Coding RNAs
platinum regimens
EPICUP assay
tumor-type specific pattern
successful development
drug sensitivity fingerprint
final clinical validation
current EPIPHARM Proof of Concept
described modest clinical benefit
Epigenetic Disruption
wide variety of ncRNAs
high-throughput tool
lincRNAs
microRNAs
EPINORC
innovative idea
T-UCRs
presence of metastatic disease
health providers
PoC
ERC Advanced Grant
taxane
recommended treatments
introduction of new image technologies
immunohistochemistry methods
empiric chemotherapy
associated company partners
snoRNAs
feasibility
project
EPIgenetics of PHARMacogenetics
heterogeneous group of cancers
better tools
piRNAs
gemcitabine
extent
loci
expected death
effective approach
months
package
proposal
patients
presentation
world
prognoses
diagnosis